Trillium Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trillium Therapeutics

TRIL 20.36

+2.0%

Nov 26 2:56 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (130)	12/18/2017 7:47:28 PM
From: scaram(o)uche	of 294

Good to hear from you! Figured you had gone searching for sunsets and hammocks. >> Fund may prefer not to show a losing biotech in its YE reports << Suspect that funds wouldn't fold and run if they thought there was promise.... this has always been a moon shot, a project that applies to ANY immunogenic cancer. And it's very unlikely that any biotech funds are in trouble, that someone is forced to fold. Best! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next